Loading

logo

Journal of Diabetes and Clinical Research

ISSN: 2689-2839

Research Article Open Access
Volume 6 | Issue 1 | DOI: https://doi.org/10.33696/diabetes.6.063

Incidence of Diabetic Mellitus among HIV Patients Receiving Antiretroviral Therapy in Ethiopia: Ten Years Retrospective Follow-up Study

Lidiya Tekle Gebreyohannes1,*, Addisu Dabi Wake1
  • 1Nursing Department, College of Health Sciences, Arsi University, Asella, Oromia Regional State, Ethiopia
+ Affiliations - Affiliations

Corresponding Author

Lidiya Tekle Gebreyohannes, lidiyat1621@gmail.com

Received Date: October 26, 2024

Accepted Date: November 13, 2024

Citation:

Gebreyohannes LT, Wake AD. Incidence of Diabetic Mellitus among HIV Patients Receiving Antiretroviral Therapy in Ethiopia: Ten Years Retrospective Follow-up Study. J Diabetes Clin Res. 2024;6(1):48-55.


Copyright: © 2024 Gebreyohannes LT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction: Diabetes mellitus (DM) is an important chronic comorbid condition that occurs in people living with the human immunodeficiency virus (HIV). It is associated with increased morbidity and mortality. Many cases of comorbidities with diabetes mellitus have been reported, particularly in areas of the world where the prevalence of HIV is high. The rate of diabetes hospitalizations among HIV-infected individuals increased from 3.9 to 8.4 per 100 hospitalizations. Although the cost of HIV care has increased, the burden of DM among people living with HIV has economic consequences.

Objectives: This study aimed to assess the incidence of DM among HIV patients receiving ART in the Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia.
Methods: Ten years retrospective follow-up study was conducted among 268 HIV patients receiving ART at Asella Referral and Teaching Hospital. HIV patients receiving ART between January 01/2013 and Dec 31/2022 were enrolled in this study. A systematic sampling technique was used to select patients’ medical charts. Data were extracted from the patients’ medical chart records from March 21 to March 23, 2023, using a data extraction format. Data were entered into Epi Data version 4.6.0.0, and exported to STATA version 14.2 for statistical analysis.

Results: A total of 268 medical charts of HIV patients receiving ART were included in the final analysis, which provided a response rate of 98.52%. The mean age of participants was 38.17 years. Among 268 HIV patients followed for 10 years, 142 (52.99%) were female, 33(49.63%) were aged between 30-40 years. Approximately 154 (57.46%) of them were urban residents. The incidence density rate (IDR) of DM in the cohort of HIV patients receiving ART during 1291.33 person-year observation was 6.20 per 1000 [95% CI: 3.10, 12.39] person-years. The cumulative incidence proportion of DM among HIV patients receiving ART was 2.99% [95% CI: 1.49, 5.88] within the 10 years follow-up period.

Conclusion: The incidence of DM among HIV patients receiving ART was relatively high. It is important to emphasize HIV patients receiving ART for early screening of DM among these patients.

Keywords

Incidence, Diabetes mellitus, ART, HIV/AIDS, Ethiopia

Recommended Articles

Ubiquitin Proteasome System Regulates Biological Particles Interaction in Particle Disease (PD) via NF-κB Signaling

Considering their outstanding mechanical character, it is inevitable to utilize titanium and titanium composite for biomedical engineering application [1-6]. However, the particles releasing from these bulks or composites of biomaterials after long term implanting in human body will cause cell apoptosis or cell death, inflammation, bone

Chest Pain in Repeated Emergency Department Visitors

Chest pain is the leading symptom in 5 to 8% of all emergency department (ED) visits and is also one of the major reasons of repeated ED visits, causing around 6% of these cases [1]. Generally, in 15 to 25% of patients with chest pain, acute myocardial infarction (AMI) is the underlying cause.

DILI, HILI, RUCAM Algorithm, and AI, the Artificial Intelligence: Provocative issues, Progress, and Proposals

Artificial Intelligence (AI) principles published in 1956 included the recommendation to use algorithms for solving complex processes. The creation of the Roussel Uclaf Causality Assessment Method (RUCAM) was published in 1993 with integration of an intelligent algorithm to solve issues of causality assessment in cases of complex suspected drug induced liver injury (DILI) cases. Other causality assessment methods (CAMs) published before the era of AI and RUCAM followed rather general principles without precise and valid algorithm.

Development of Metal Oxide Nanoparticles as Semiconductors

The variety of methods employed during the fabrication of MONPs can alter the characteristics and control the properties of the obtained nano-oxides. The reaction mechanisms and, therefore, the functionality of nanostructured MOx depend on their composition

Multidisciplinary Acute Care of Central Retinal Artery Occlusion with a Stroke Paradigm: A Call to Action

Central retinal artery occlusion (CRAO) is an ophthalmologic emergency that can result in permanent vision loss. Over 25% of CRAO are associated with acute cerebral ischemia, and there are many parallels between CRAO and acute ischemic stroke. There are no definitive treatment algorithms for CRAO, however there may be opportunities to treat CRAO as an “eye stroke”. Given the similarities to acute ischemic stroke, multidisciplinary involvement and stroke algorithms should be considered and tested for this disease.

Full Text
Cite
Download PDF
Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More